FR2133979A1 - - Google Patents
Info
- Publication number
- FR2133979A1 FR2133979A1 FR7214052A FR7214052A FR2133979A1 FR 2133979 A1 FR2133979 A1 FR 2133979A1 FR 7214052 A FR7214052 A FR 7214052A FR 7214052 A FR7214052 A FR 7214052A FR 2133979 A1 FR2133979 A1 FR 2133979A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13618671A | 1971-04-21 | 1971-04-21 | |
| US13818671A | 1971-04-21 | 1971-04-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2133979A1 true FR2133979A1 (cs) | 1972-12-01 |
| FR2133979B1 FR2133979B1 (cs) | 1975-10-31 |
Family
ID=26834087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7214052A Expired FR2133979B1 (cs) | 1971-04-21 | 1972-04-20 |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2219408A1 (cs) |
| FR (1) | FR2133979B1 (cs) |
| GB (1) | GB1356763A (cs) |
| NL (1) | NL7204972A (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011258217B2 (en) * | 2010-05-26 | 2016-12-15 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| CN111944340A (zh) * | 2020-08-21 | 2020-11-17 | 何瑞坚 | 一种耐盐雾防锈涂料 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| DK2612862T3 (en) | 2004-05-13 | 2016-12-05 | Icos Corp | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| EP3427739A1 (en) | 2008-11-13 | 2019-01-16 | Gilead Calistoga LLC | Therapies for hematologic malignancies |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| EP2411391A1 (en) | 2009-03-24 | 2012-02-01 | Gilead Calistoga LLC | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| AU2010239312A1 (en) | 2009-04-20 | 2011-11-10 | Gilead Calistoga Llc | Methods of treatment for solid tumors |
| WO2011011550A1 (en) | 2009-07-21 | 2011-01-27 | Calistoga Pharmaceuticals Inc. | Treatment of liver disorders with pi3k inhibitors |
| CA2824047C (en) * | 2011-01-11 | 2019-06-18 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| CA2864305C (en) | 2012-03-05 | 2021-02-16 | Gilead Calistoga Llc | Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one |
| US9708327B2 (en) | 2013-12-20 | 2017-07-18 | Gilead Calistoga Llc | Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
| PL3083630T3 (pl) | 2013-12-20 | 2020-02-28 | Gilead Calistoga Llc | Sposoby otrzymywania inhibitorów 3-kinazy fosfatydyloinozytolu |
| US11021467B2 (en) | 2014-06-13 | 2021-06-01 | Gilead Sciences, Inc. | Phosphatidylinositol 3-kinase inhibitors |
-
1972
- 1972-04-13 NL NL7204972A patent/NL7204972A/xx unknown
- 1972-04-18 GB GB1791772A patent/GB1356763A/en not_active Expired
- 1972-04-20 DE DE19722219408 patent/DE2219408A1/de active Pending
- 1972-04-20 FR FR7214052A patent/FR2133979B1/fr not_active Expired
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011258217B2 (en) * | 2010-05-26 | 2016-12-15 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| EP2576540B1 (en) * | 2010-05-26 | 2019-09-04 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
| CN111944340A (zh) * | 2020-08-21 | 2020-11-17 | 何瑞坚 | 一种耐盐雾防锈涂料 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1356763A (en) | 1974-06-12 |
| DE2219408A1 (de) | 1972-10-26 |
| FR2133979B1 (cs) | 1975-10-31 |
| NL7204972A (cs) | 1972-10-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |